Glepaglutide Improves Short Bowel Syndrome Patients’ Ability to Get Nutrients from Food, Trial Shows
News
Zealand Pharma‘s glepaglutide (ZP1848) improves short bowel syndrome patients’ ability to absorb nutrients from food, according to a Phase 2 clinical trial. The condition, also known as SBS, occurs when ... Read more